<!doctype html><html><head><meta charset=utf-8><title>Schizophrenia might be treated by folic acid, vitamin B12 and vitamin D</title>
<link rel=stylesheet href="/css/main.css?v=1753303882"><link rel=stylesheet href="/css/pagination.css?v=1753303882"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303882"></script><script src="/js/search.js?v=1753303882"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Schizophrenia might be treated by folic acid, vitamin B12 and vitamin D</h1><time>May 24, 2014</time><div data-pagefind-body><h3 id=vitamin-supplementation-in-the-treatment-of-schizophrenia>Vitamin Supplementation in the Treatment of Schizophrenia.</h3><p>CNS Drugs. 2014 May 21. <span>[Epub ahead of print]</span></p><p>Brown HE 1, Roffman JL.</p><p>1 Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA, <a href=mailto:hebrown@partners.org>hebrown@partners.org</a>.</p><p>This article reviews the current literature addressing the treatment of schizophrenia with vitamin supplementation. It describes the important roles that vitamins play in normal metabolism, and reviews the evidence pertaining to vitamin deficiency and supplementation in patients with schizophrenia. There is mounting evidence suggesting that vitamin supplementation, in particular with, may be important in treatment within certain subgroups of patients. There is a need for larger randomized controlled trials, and further studies examining the incidence of schizophrenia in countries with poor prenatal care and malnutrition, as well as in countries that have adopted mandatory folic acid fortification of grain products, are recommended.</p><p>PMID: 24846474</p><p><strong><a href=http://link.springer.com/article/10.1007/s40263-014-0172-4%20>Publisher charges $50 for the PDF</a></strong></p><h3 id=references>References</h3><ol><li><p>Rabinowitz J, Levine SZ, Garibaldi G, Bugarski-Kirola D, Berardo CG, Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res. 2012;137(1–3):147–50. doi:10.1016/j.schres.2012.01.015. CrossRef</p></li><li><p>Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10(1):79–104. doi:10.1038/sj.mp.4001556. CrossRef</p></li><li><p>Kemperman RF, Veurink M, van der Wal T, Knegtering H, Bruggeman R, Fokkema MR, et al. Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids. 2006;74(2):75–85. doi:10.1016/j.plefa.2005.11.004. CrossRef</p></li><li><p>Muntjewerff JW, van der Put N, Eskes T, Ellenbroek B, Steegers E, Blom H, et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res. 2003;121(1):1–9. CrossRef</p></li><li><p>Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 2010;175(1–2):47–53. doi:10.1016/j.psychres.2009.01.013. CrossRef</p></li><li><p>Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry. 2004;161(9):1705–8. doi:10.1176/appi.ajp.161.9.1705. CrossRef</p></li><li><p>Menkes DB, Lancaster K, Grant M, Marsh RW, Dean P, du Toit SA. Vitamin D status of psychiatric inpatients in New Zealand’s Waikato region. BMC Psychiatry. 2012;12:68. doi:10.1186/1471-244X-12-68. CrossRef</p></li><li><p>Berg AO, Melle I, Torjesen PA, Lien L, Hauff E, Andreassen OA. A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. J Clin Psychiatry. 2010;71(12):1598–604. doi:10.4088/JCP.09m05299yel. CrossRef</p></li><li><p>Gracious BL, Finucane TL, Friedman-Campbell M, Messing S, Parkhurst MN. Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry. 2012;12:38. doi:10.1186/1471-244X-12-38. CrossRef</p></li><li><p>Crews M, Lally J, Gardner-Sood P, Howes O, Bonaccorso S, Smith S, et al. Vitamin D deficiency in first episode psychosis: a case-control study. Schizophr Res. 2013;150(2–3):533–7. doi:10.1016/j.schres.2013.08.036. CrossRef</p></li><li><p>Belvederi Murri M, Respino M, Masotti M, Innamorati M, Mondelli V, Pariante C, et al. Vitamin D and psychosis: mini meta-analysis. Schizophr Res. 2013;150(1):235–9. doi:10.1016/j.schres.2013.07.017. CrossRef</p></li><li><p>Suboticanec K, Folnegovic-Smalc V, Turcin R, Mestrovic B, Buzina R. Plasma levels and urinary vitamin C excretion in schizophrenic patients. Human Nutr Clin Nutr. 1986;40(6):421–8.</p></li><li><p>D’Souza B, D’Souza V. Oxidative injury and antioxidant vitamins E and C in Schizophrenia. Indian J Clin Biochem IJCB. 2003;18(1):87–90. doi:10.1007/BF02867671. CrossRef</p></li><li><p>Lieberman MMA, Peet A. Marks’ basic medical biochemistry: a clinical approach. 4th ed. Philadelphia: PA Lippincott Williams & Wilkins; 2013.</p></li><li><p><a href=http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064928.htm>http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064928.htm</a>. Accessed November 15 2013.</p></li><li><p>Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res. 2013;47(2):197–207. doi:10.1016/j.jpsychires.2012.10.005. CrossRef</p></li><li><p>Hoffer A. Nutrition and schizophrenia. Can Fam Phys Med Fam Can. 1975;21(4):78–82.</p></li><li><p>Hoffer A, Prousky J. Successful treatment of schizophrenia requires optimal daily doses of vitamin B3. Altern Med Rev J Clin Ther. 2008;13(4):287–91.</p></li><li><p>Petrie WM, Ban TA. Vitamins in psychiatry. Do they have a role? Drugs. 1985;30(1):58–65. CrossRef</p></li><li><p>Haidemenos A, Kontis D, Gazi A, Kallai E, Allin M, Lucia B. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry. 2007;31(6):1289–96. doi:10.1016/j.pnpbp.2007.05.011. CrossRef</p></li><li><p>Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC, et al. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry. 2008;63(1):42–8. doi:10.1016/j.biopsych.2006.12.017. CrossRef</p></li><li><p>Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH, et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2008;147B(6):990–5. doi:10.1002/ajmg.b.30684. CrossRef</p></li><li><p>Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, et al. MTHFR 677C → T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val → Met. Proc Natl Acad Sci USA. 2008;105(45):17573–8. doi:10.1073/pnas.0803727105. CrossRef</p></li><li><p>Roffman JL, Nitenson AZ, Agam Y, Isom M, Friedman JS, Dyckman KA, et al. A hypomethylating variant of MTHFR, 677C > T, blunts the neural response to errors in patients with schizophrenia and healthy individuals. PloS one. 2011;6(9):e25253. doi:10.1371/journal.pone.0025253. CrossRef</p></li><li><p>Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature Genet. 2008;40(7):827–34. doi:10.1038/ng.171. CrossRef</p></li><li><p>Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336(8712):392–5. CrossRef</p></li><li><p>Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, et al. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biological Psychiatry. 2006;60(3):265–9. doi:10.1016/j.biopsych.2005.10.009. CrossRef</p></li><li><p>Hill M, Shannahan K, Jasinski S, Macklin EA, Raeke L, Roffman JL, et al. Folate supplementation in schizophrenia: a possible role for MTHFR genotype. Schizophr Res. 2011;127(1–3):41–5. doi:10.1016/j.schres.2010.12.006. CrossRef</p></li><li><p>Roffman JL, Lamberti JS, Achtyes E, Macklin EA, Galendez GC, Raeke LH, et al. Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry. 2013;70(5):481–9. doi:10.1001/jamapsychiatry.2013.900. CrossRef</p></li><li><p>Fatemi SH. Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia. Schizophr Res. 2010;118(1–3):303–4. doi:10.1016/j.schres.2010.01.018. CrossRef</p></li><li><p>Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. Schizophrenia after prenatal famine. Further evidence. Arch General Psychiatry. 1996;53(1):25–31. CrossRef</p></li><li><p>St Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959–1961. JAMA J Am Med Assoc. 2005;294(5):557–62. doi:10.1001/jama.294.5.557. CrossRef</p></li><li><p>MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131–7.</p></li><li><p>Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull. 2008;34(6):1054–63. doi:10.1093/schbul/sbn096. CrossRef</p></li><li><p>Brown AS, Bottiglieri T, Schaefer CA, Quesenberry CP Jr, Liu L, Bresnahan M, et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch General Psychiatry. 2007;64(1):31–9. doi:10.1001/archpsyc.64.1.31. CrossRef</p></li><li><p>Dealberto MJ. Clinical symptoms of psychotic episodes and 25-hydroxy vitamin D serum levels in black first-generation immigrants. Acta Psychiatrica Scand. 2013;128(6):475–87. doi:10.1111/acps.12086. CrossRef</p></li><li><p>Graham KA, Keefe RS, Lieberman JA, Calikoglu AS, Lansing KM, Perkins DO. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early intervention in psychiatry. 2014. doi:10.1111/eip.12122.</p></li><li><p>McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch General Psychiatry. 2010;67(9):889–94. doi:10.1001/archgenpsychiatry.2010.110. CrossRef</p></li><li><p>Sullivan S, Wills A, Lawlor D, McGrath J, Zammit S. Prenatal vitamin D status and risk of psychotic experiences at age 18 years-a longitudinal birth cohort. Schizophr Res. 2013;148(1–3):87–92. doi:10.1016/j.schres.2013.05.015. CrossRef</p></li><li><p>McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Jarvelin MR, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res. 2004;67(2–3):237–45. doi:10.1016/j.schres.2003.08.005. CrossRef</p></li><li><p>Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res. 2003;62(3):195–204. CrossRef</p></li><li><p>Bentsen H, Osnes K, Refsum H, Solberg DK, Bohmer T. A randomized placebo-controlled trial of an <strong>omega-3</strong> fatty acid and vitamins E + C in schizophrenia. Transl Psychiatry. 2013;3:e335. doi:10.1038/tp.2013.110. CrossRef</p></li><li><p>Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin Psychopharmacol. 1987;7(4):282–3. CrossRef</p></li><li><p>Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology. 2005;182(4):494–8. doi:10.1007/s00213-005-0117-1. CrossRef</p></li><li><p>Bao Y, Ibram G, Blaner WS, Quesenberry CP, Shen L, McKeague IW, et al. Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophr Res. 2012;137(1–3):159–65. doi:10.1016/j.schres.2012.02.004. CrossRef</p></li><li><p>Mason JB. Unraveling the complex relationship between folate and cancer risk. BioFactors. 2011;37(4):253–60. doi:10.1002/biof.174. CrossRef</p></li><li><p>Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. 2013;381(9871):1029–36. doi:10.1016/S0140-6736(12)62001-7. CrossRef</p></li></ol><hr><h2 id=see-also-vitamindwiki>See also VitaminDWiki</h2><ul><li><p><a href=/posts/overview-schizophrenia-and-vitamin-d>Overview Schizophrenia and Vitamin D</a></p></li><li><p><a href=/posts/results-of-many-blood-tests-in-australia-deficiencies-only-in-vitamin-d-iodine-and-vitamin-b-12>Results of many blood tests in Australia – deficiencies only in Vitamin D, Iodine, and Vitamin B-12 – Dec 2015</a></p></li></ul></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/b12.html><span class=tag>B12</span></a>
<a href=/tags/cancer.html><span class=tag>cancer</span></a>
<a href=/tags/cognitive.html><span class=tag>Cognitive</span></a>
<a href=/tags/iodine.html><span class=tag>iodine</span></a>
<a href=/tags/omega-3.html><span class=tag>omega 3</span></a>
<a href=/tags/omega-3-and-pregnancy.html><span class=tag>omega 3 and pregnancy</span></a>
<a href=/tags/pregnancy.html><span class=tag>pregnancy</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a></div><div data-pagefind-meta=tags hidden>B12, cancer, Cognitive, iodine, omega 3, omega 3 and pregnancy, pregnancy, vitamin d</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303882"></script><script src="/js/tiki-redirects.js?v=1753303882"></script><script src="/js/lightspa.js?v=1753303882"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303882",indexUrl:"/search/search_index.json.gz?v=1753303882"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303882"></script></body></html>